---
title: Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS*
  Collaboration
date: '2024-06-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38878126/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240616180959&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Despite the lack of evidence, and contrary to guidelines''
  recommendations, about 5% of respondents stated that TH may be indicated as a treatment
  for obesity in euthyroid patients resistant to life-style interventions. This opinion
  was associated with (i) respondent characteristics: being non-endocrinologist, working
  in private practice, treating a small number of hypothyroid patients annually and
  (ii) national characteristics: prevalence of obesity, Eastern Europe, low GNI and
  ...'
disable_comments: true
---
CONCLUSIONS: Despite the lack of evidence, and contrary to guidelines' recommendations, about 5% of respondents stated that TH may be indicated as a treatment for obesity in euthyroid patients resistant to life-style interventions. This opinion was associated with (i) respondent characteristics: being non-endocrinologist, working in private practice, treating a small number of hypothyroid patients annually and (ii) national characteristics: prevalence of obesity, Eastern Europe, low GNI and ...